CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shandong Keyuan Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shandong Keyuan Pharmaceutical Co Ltd
Phone: +86 53188729558p:+86 53188729558 JI'NAN, SDG  251601  China Ticker: 301281301281
Business Summary
Shandong Keyuan Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical APIs and their preparation products. The Company's main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and others. The Company's products are used in hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The Company conducts its operations mainly in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager HongshengJiang 50 5/28/2024 5/1/2023
Vice Chairman of the Board XiaohongZou 65 10/23/2018 9/1/2015
Finance Director, Deputy General Manager, Secretary of the Board ChunhuaLi 47 9/30/2024 6/5/2020
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 624 (As of 12/31/2023)
Outstanding Shares: 108,290,000 (As of 10/8/2024)
Shareholders: 13,648
Stock Exchange: SHE
Fax Number: +86 53184779766


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024